Caption Management, LLC Kiniksa Pharmaceuticals, Ltd. Transaction History

Caption Management, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$17.63 - $21.74 $105,780 - $130,439	6,000 New	6,000 $118,000
Q2 2022 Aug 15, 2022	SELL	$7.6 - $11.41 $489,736 - $735,248	-64,439 Reduced 98.2%	1,184 $11,000
Q1 2022 May 13, 2022	BUY	$9.3 - $12.37 $598,529 - $796,108	64,358 Added 5087.59%	65,623 $651,000
Q4 2021 Feb 11, 2022	SELL	$10.39 - $15.15 $168,681 - $245,960	-16,235 Reduced 92.77%	1,265 $14,000
Q3 2021 Nov 12, 2021	BUY	$11.39 - $16.23 $62,645 - $89,265	5,500 Added 45.83%	17,500 $199,000
Q2 2021 Aug 16, 2021	SELL	$13.22 - $19.09 $295,334 - $426,470	-22,340 Reduced 65.06%	12,000 $168,000
Q1 2021 May 17, 2021	BUY	$16.68 - $23.97 $447,691 - $643,354	26,840 Added 357.87%	34,340 $635,000
Q3 2020 Nov 16, 2020	BUY	$15.21 - $25.53 $114,075 - $191,475	7,500 New	7,500 $116,000

1.95M

Ticker KNSA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 34,470,400
Market Cap $687M
Description
Kiniksa Pharmaceuticals, Ltd., a biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases with significant unmet medical needs worldwide. Its product candidates include ARCALYST, an interleukin-1alpha and interleukin-1beta, for the treatm...

Get notified when there are updates to the investment portfolio of Caption Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Caption Management, LLC with notifications on news.